Retraction
Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant Glioma
Paper Information
Record ID:
56374
Author(s):
Journal:
Publication Date:
February 23, 2010
Retraction Date:
August 29, 2024
(1.2 year years ago)
Subjects:
Institutions:
- Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
- Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
- VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
- Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, Alabama, USA
- The Brain Tumor Center, The University of Chicago, Chicago, Illinois, USA
- Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
- Department of Medicine, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
- VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.ymthe.2024.08.020Additional Notes:
see also: https://pubpeer.com/publications/2736C7BC1BC51DCAE0AB6216E17255
Citations (42)
42
Total Citations1
Post-Retraction(2.4%)
41
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
305
Days since retraction (latest)
An assembled molecular signaling map of interleukin-24: a resource to decipher its multifunctional immunoregulatory role in pathophysiological conditions
Anjana Aravind, Vineetha Shaji, Mukhtar Ahmed et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Jun 2025
305 days after retraction
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
Yazhe Wang, Shipra Malik, Hee‐Won Suh et al. (11 authors)
Science Advances
Open Access
Published: Feb 2023
28 citations
28 citations
568 days before retraction
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
Jinkal Modi, Abhishek Roy, Anjan K. Pradhan et al. (19 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2021
14 citations
14 citations
981 days before retraction
Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
Praveen Bhoopathi, Anjan K. Pradhan, Santanu Maji et al. (6 authors)
Cancers
Open Access
Published: Feb 2021
6 citations
6 citations
1288 days before retraction
Umbilical cord‐derived mesenchymal stromal/stem cells expressing IL‐24 induce apoptosis in gliomas
Shaochen Fan, Huasong Gao, Wei Ji et al. (10 authors)
Journal of Cellular Physiology
Published: Jul 2019
26 citations
26 citations
1875 days before retraction
Autophagy in glioma cells: An identity crisis with a clinical perspective
Ilya V. Ulasov, Guido Lenz, Maciej S. Lesniak
Cancer Letters
Published: Apr 2018
27 citations
27 citations
2316 days before retraction
Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases
Mitchell E. Menezes, Praveen Bhoopathi, Anjan K. Pradhan et al. (9 authors)
Advances in cancer research
Open Access
Published: Jan 2018
49 citations
49 citations
2432 days before retraction
Cancer terminator viruses (<i>CTV</i>): A better solution for viral‐based therapy of cancer
Luni Emdad, Swadesh K. Das, Xiang‐Yang Wang et al. (5 authors)
Journal of Cellular Physiology
Open Access
Published: Dec 2017
18 citations
18 citations
2438 days before retraction
Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci
Bo Liu, Fei Chen, Yong Wu et al. (11 authors)
Oncotarget
Open Access
Published: Mar 2017
23 citations
23 citations
2712 days before retraction
The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma
Natalia Fajardo, Coby Meijer, Frank A.E. Kruyt
Biochemical Pharmacology
Published: Apr 2016
118 citations
118 citations
3043 days before retraction
RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway
Yu Yan, Yugang Jiang
International Journal of Molecular Medicine
Open Access
Published: Nov 2015
41 citations
41 citations
3195 days before retraction
Suppression of Her2/Neu mammary tumor development in <i>mda-7/IL-24</i> transgenic mice
Youjun Li, Guodong Liu, Lei Xia et al. (13 authors)
Oncotarget
Open Access
Published: Oct 2015
17 citations
17 citations
3247 days before retraction
Current Status of Gene Therapy for Brain Tumors∗
Jianfang Ning, Samuel D. Rabkin
Elsevier eBooks
Open Access
Published: Jan 2015
2 citations
2 citations
3528 days before retraction
Stem cells as cellular vehicles for gene therapy against glioblastoma.
Wei Wang, Fanlong Liu, Bingyu Xiang et al. (5 authors)
PubMed
Published: Jan 2015
5 citations
5 citations
3528 days before retraction
Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach
Siddik Sarkar, Bridget A. Quinn, Xue‐Ning Shen et al. (8 authors)
Molecular Pharmacology
Open Access
Published: Dec 2014
8 citations
8 citations
3558 days before retraction
Gene Therapies for Cancer: Strategies, Challenges and Successes
Swadesh K. Das, Mitchell E. Menezes, Shilpa Bhatia et al. (7 authors)
Journal of Cellular Physiology
Open Access
Published: Sep 2014
245 citations
245 citations
3645 days before retraction
Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients
Lin Wang, Zhien Feng, Huanhuan Wu et al. (8 authors)
Tumor Biology
Published: Aug 2014
16 citations
16 citations
3678 days before retraction
Interleukin-10 Superfamily and Cancer
Arseniy E. Yuzhalin, Anton G. Kutikhin
Elsevier eBooks
Published: Jul 2014
3688 days before retraction
Interleukin-1 Superfamily and Cancer
Arseniy E. Yuzhalin, Anton G. Kutikhin
Elsevier eBooks
Published: Jul 2014
1 citation
1 citation
3688 days before retraction
Adenoviral vector-mediated gene therapy for gliomas: coming of age
María G. Castro, Marianela Candolfi, Thomas J. Wilson et al. (10 authors)
Expert Opinion on Biological Therapy
Open Access
Published: Apr 2014
52 citations
52 citations
3775 days before retraction
Paper citing Inhibition of Multiple Protective Signaling Pathwa...
Unknown Authors
Unknown Journal
Published: Jan 2014
3863 days before retraction
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
Hossein A. Hamed, Swadesh K. Das, Upneet K. Sokhi et al. (11 authors)
Cancer Biology & Therapy
Open Access
Published: Oct 2013
22 citations
22 citations
3977 days before retraction
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-<i>CTV</i>)
Belal Azab, Rupesh Dash, Swadesh K. Das et al. (15 authors)
Journal of Cellular Physiology
Open Access
Published: Jul 2013
22 citations
22 citations
4077 days before retraction
Is Mda-7/IL-24 a Potential Target and Biomarker for Enhancing Drug Sensitivity in Human Glioma U87 Cell Line?
Qin Wang, Yu Zhu, Ping Yang
The Anatomical Record
Open Access
Published: Jun 2013
8 citations
8 citations
4084 days before retraction
Histone Deacetylase Inhibitors Interact with Melanoma Differentiation Associated-7/Interleukin-24 to Kill Primary Human Glioblastoma Cells
Hossein A. Hamed, Adly Yacoub, Margaret A. Park et al. (9 authors)
Molecular Pharmacology
Open Access
Published: May 2013
25 citations
25 citations
4130 days before retraction
Inhibitory Effect of Melanoma Differentiation Associated Gene-7/Interleukin-24 on Invasion In Vitro of Human Melanoma Cancer Cells
Biwen Lin, Ze-long Jiao, Jianfeng Fan et al. (8 authors)
Journal of Korean Medical Science
Open Access
Published: Jan 2013
10 citations
10 citations
4258 days before retraction
Current status of gene therapy for brain tumors
Andrea M. Murphy, Samuel D. Rabkin
Translational research
Open Access
Published: Dec 2012
59 citations
59 citations
4279 days before retraction
Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy
Donavon Charles Hiss, Burtram C. Fielding
Expert Opinion on Biological Therapy
Published: Jul 2012
2 citations
2 citations
4430 days before retraction
A First-Generation Multi-Functional Cytokine for Simultaneous Optical Tracking and Tumor Therapy
Shawn Hingtgen, Randa Kasmieh, Elizabeth Elbayly et al. (12 authors)
PLoS ONE
Open Access
Published: Jul 2012
32 citations
32 citations
4432 days before retraction
Enhancing CHK1 inhibitor lethality in glioblastoma
Yong Tang, Yun Dai, Steven Grant et al. (4 authors)
Cancer Biology & Therapy
Open Access
Published: Apr 2012
43 citations
43 citations
4533 days before retraction
Cancer Terminator Viruses and Approaches for Enhancing Therapeutic Outcomes
Swadesh K. Das, Siddik Sarkar, Rupesh Dash et al. (7 authors)
Advances in cancer research
Open Access
Published: Jan 2012
30 citations
30 citations
4624 days before retraction
Targeting Mcl-1 for the therapy of cancer
Bridget A. Quinn, Rupesh Dash, Belal Azab et al. (21 authors)
Expert Opinion on Investigational Drugs
Open Access
Published: Aug 2011
191 citations
191 citations
4759 days before retraction
Enhanced delivery of <i>mda‐</i>7/IL‐24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI‐97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells
Belal Azab, Rupesh Dash, Swadesh K. Das et al. (17 authors)
Journal of Cellular Physiology
Open Access
Published: Jul 2011
47 citations
47 citations
4788 days before retraction
The potential of virus-based gene therapies for treatment of metastatic kidney cancer
Paul Dent, David T. Curiel, Paul B. Fisher
Expert Review of Anticancer Therapy
Published: Jun 2011
1 citation
1 citation
4838 days before retraction
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to <i>mda</i> -7/IL-24–mediated toxicity
Rupesh Dash, Belal Azab, Bridget A. Quinn et al. (19 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: May 2011
121 citations
121 citations
4861 days before retraction
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic.
Rupesh Dash, Belal Azab, Xue‐Ning Shen et al. (14 authors)
PubMed
Published: Jan 2011
32 citations
32 citations
4989 days before retraction
Glioblastoma Multiforme: Use of Adenoviral Vectors
Thomas Wirth, Haritha Samaranayake, Seppo Ylä‐Herttuala
Springer eBooks
Published: Jan 2011
4989 days before retraction
Enhancing<i>mda</i>-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery
Patrick Eulitt, Margaret A. Park, Hamed Hossein et al. (10 authors)
Cancer Biology & Therapy
Open Access
Published: Dec 2010
30 citations
30 citations
5006 days before retraction
A Serotype 5/3 Adenovirus Expressing MDA-7/IL-24 Infects Renal Carcinoma Cells and Promotes Toxicity of Agents That Increase Ros and Ceramide Levels
Margaret A. Park, Hossein A. Hamed, Clint Mitchell et al. (15 authors)
Molecular Pharmacology
Open Access
Published: Nov 2010
28 citations
28 citations
5021 days before retraction
mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity
Rupesh Dash, Sujit K. Bhutia, Belal Azab et al. (20 authors)
Cytokine & Growth Factor Reviews
Open Access
Published: Oct 2010
102 citations
102 citations
5081 days before retraction
The development of MDA-7/IL-24 as a cancer therapeutic
Paul Dent, Adly Yacoub, Hossein A. Hamed et al. (20 authors)
Pharmacology & Therapeutics
Open Access
Published: Aug 2010
58 citations
58 citations
5121 days before retraction
Small Molecule Inhibitors of MAPK and PI3K Pathways Enhance MDA-7 Lethality in Renal Cell Carcinoma
Patrick Eulitt
Unknown Journal
Published: Jan 2010
5354 days before retraction
Quick Stats
Total Citations:
42
Years Since Retraction:
1.2 year
Open Access:
Yes
Last Checked:
Jul 24, 2025